<?xml version="1.0" encoding="UTF-8"?>
<definitions publication-date="2024-08-01" publication-type="official">
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q</classification-symbol><definition-title> MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS  (immunoassay <class-ref scheme="cpc">G01N33/53</class-ref>); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Processes in which there is a direct or indirect qualitative or quantitative measurement or test of a material which contains enzymes, nucleic acids or microorganisms.</paragraph-text><paragraph-text type="body">Processes in which a material containing enzymes, nucleic acids or microorganisms is used to perform a qualitative or quantitative measurement or test, e.g. testing for antimicrobial activity or cholesterol, geomicrobiological testing.</paragraph-text><paragraph-text type="body">In vivo or in vitro or in silico measuring or testing processes involving nucleic acid e.g. nucleic acid hybridisation including PCR (Polymerase Chain Reaction).</paragraph-text><paragraph-text type="body">Compositions or test papers containing enzymes, nucleic acids or microorganisms which can be used to detect or identify a chemical compound or composition, e.g. paper strips for the testing of blood sugar.</paragraph-text><paragraph-text type="body">Compositions or test papers distinguished by the use of indicators which can be used to detect or identify the presence of enzymes, nucleic acids or microorganisms.</paragraph-text><paragraph-text type="body">Processes of making such test compositions.</paragraph-text><paragraph-text type="body">Processes involving enzymes or microorganisms in which a process parameter is measured and that or another process parameter is varied in response to such measurement, i.e. condition responsive control.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Controlling or regulating in general is classified in <class-ref scheme="cpc">G05</class-ref>.</paragraph-text><paragraph-text type="body">The codes of subclass <class-ref scheme="cpc">C12R</class-ref>&#160;are only for use as Indexing codes associated with subclasses <class-ref scheme="cpc">C12C</class-ref> - <class-ref scheme="cpc">C12Q</class-ref>, so as to provide information concerning the microorganisms used in the processes classified in these subclasses.</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Immunoassay </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/53</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay with enzyme label</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/535</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay with the carrier being a biological cell or cell fragment</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/554</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay for microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/569</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay for venereal diseases</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/571</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay for enzymes and isoenzymes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/573</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay for cancer</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/574</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay for hepatitis</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/576</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microorganisms per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Human, animal or plant cells per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Viruses per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N7/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12N11/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Investigating or analysing materials by determining their chemical or physical properties</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical analysis involving blood sugar, e.g. galactose</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/66</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical analysis involving proteins, peptides and amino acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical analysis involving lipids, e.g. cholesterol</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/92</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In this subclass, in absence of an indication to the contrary, classification is made in the last appropriate place.</paragraph-text><paragraph-text type="body">In this subclass, test media are classified in the appropriate group for the relevant test process.</paragraph-text><paragraph-text type="body">In this subclass, bacteria, fungi, viruses, protozoa and algae are considered as microorganisms.</paragraph-text><paragraph-text type="body">In this subclass, sub-cellular parts, unless specifically provided for, are classified with the whole cell.</paragraph-text><paragraph-text type="subheading">Combination Sets [C-Sets]:</paragraph-text><paragraph-text type="body">In this subclass, C-Sets classification is applied to the following groups, listed in the table below, if the document discloses a pertinent combination of technical features that cannot be covered by the allocation of a single symbol. The fourth column of the table indicates the place where the detailed information about the C-Sets construction and the associated syntax rules can be found, in the definition section &quot;Special rules of classification&quot;. </paragraph-text><table>
<table-row><table-column><paragraph-text type="body">C-SETS ID</paragraph-text></table-column><table-column><paragraph-text type="body">BASE SYMBOL</paragraph-text></table-column><table-column><paragraph-text type="body">SUBSEQUENT SYMBOLS</paragraph-text></table-column><table-column><paragraph-text type="body">C-SETS FORMULA; LOCATION OF C-SETS RULES</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">#C12Qa</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/68</class-ref> - <class-ref scheme="cpc">C12Q1/6874</class-ref>, <class-ref scheme="cpc">C12Q1/6897</class-ref>, <class-ref scheme="cpc">C12Q1/70</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">(<class-ref scheme="cpc">C12Q</class-ref>, <class-ref scheme="cpc">C12Q</class-ref>); measuring or testing processes involving in a nucleic acid; see <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">#C12Na</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/10</class-ref> - <class-ref scheme="cpc">C12N15/1096</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">(<class-ref scheme="cpc">C12N</class-ref>, <class-ref scheme="cpc">C12Q</class-ref>); DNA or RNA isolation/preparation process and cell culture components; see <class-ref scheme="cpc">C12N15/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">#C12Nb</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/64</class-ref> - <class-ref scheme="cpc">C12N15/66</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">(<class-ref scheme="cpc">C12N</class-ref>, <class-ref scheme="cpc">C12Q</class-ref>); general methods for preparing vectors; see <class-ref scheme="cpc">C12N15/64</class-ref></paragraph-text></table-column></table-row></table><paragraph-text type="body">The specific C-Sets rule is located at only one place of the base symbol in the section &quot;Special rules of classification&quot; in the definition. If the C-Sets rule is applicable to all groups of a subclass, it is located at the subclass level only. If the same C-Sets rule is applicable to multiple groups or subgroups within the same subclass, the C-Sets rule is placed at the highest group or subgroup of the multiple groups.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Enzyme</paragraph-text></table-column><table-column><paragraph-text type="body">Proteinaceous material which causes a chemical change in a starting material without being consumed in the reaction.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Involving</paragraph-text></table-column><table-column><paragraph-text type="body">When used in relation to a substance, includes the testing for the substance as well as employing the substance as a determinant or reactant in a test for a different substance.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microorganism</paragraph-text></table-column><table-column><paragraph-text type="body">For the purposes of classification, this term includes bacteria, fungi, viruses, protozoa and algae.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acid</paragraph-text></table-column><table-column><paragraph-text type="body">Comprises nucleic acids as in vitro compounds as well as sub-cellular parts in vivo like chromosome territories within the nucleus, plasmids, gene sequences, genetic information, mutations, polymorphisms such as SNPs, in silico base sequences, aptamers (ligand binding nucleic acids) and ribozymes (catalytic active RNA molecules).</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/00</classification-symbol><definition-title>Measuring or testing processes involving enzymes, nucleic acids or microorganisms  (measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, <class-ref scheme="cpc">C12M1/34</class-ref>); Compositions therefor; Processes of preparing such compositions</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Processes in which there is a direct or indirect qualitative or quantitative measurement or test of a material which contains enzymes, nucleic acids or microorganisms. </paragraph-text><paragraph-text type="body">Processes in which a material containing enzymes, nucleic acids or microorganisms is used to perform a qualitative or quantitative measurement or test, e.g. testing for antimicrobial activity or cholesterol, geomicrobiological testing.</paragraph-text><paragraph-text type="body">In vivo or in vitro or in silico measuring or testing processes involving nucleic acid e.g. nucleic acid hybridisation including Polymerase Chain Reaction [PCR]. See section range <class-ref scheme="cpc">C12Q1/68</class-ref>&#160;- <class-ref scheme="cpc">C12Q1/708</class-ref>.</paragraph-text><paragraph-text type="body">Compositions or test papers containing enzymes, nucleic acids or microorganisms which can be used to detect or identify a chemical compound or composition, e.g. paper strips for the testing of blood sugar.</paragraph-text><paragraph-text type="body">Compositions or test papers distinguished by the use of indicators which can be used to detect or identify the presence of enzymes, nucleic acids or microorganisms.</paragraph-text><paragraph-text type="body">Processes of making such test compositions.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12M1/34</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Apparatus for condition-responsive control processes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12M1/36</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microorganisms per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Human, animal or plant cells per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Viruses per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N7/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12N11/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Investigating or analysing materials by determining their chemical or physical properties</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Observation of the progress or of the result of processes specified in this group by any of the methods specified in groups <class-ref scheme="cpc">G01N3/00</class-ref> - <class-ref scheme="cpc">G01N29/00</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Investigating or analysing biological material</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/48</class-ref>- <class-ref scheme="cpc">G01N33/98</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Testing involving plant cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/5097</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay for plant cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/56961</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay for animal cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/56966</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical analysis involving blood sugar, e.g. galactose</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/66</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical analysis involving proteins, peptides and amino acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> Chemical analysis involving lipids, e.g. cholesterol</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/92</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In this group, test media are classified in the appropriate group for the relevant test process.</paragraph-text><paragraph-text type="body">Classification in main group <class-ref scheme="cpc">C12Q1/00</class-ref> and sub-groups <class-ref scheme="cpc">C12Q1/001</class-ref> - <class-ref scheme="cpc">C12Q1/66</class-ref> is further refined using Indexing Codes from the range <class-ref scheme="cpc">C12Q2304/00</class-ref> - <class-ref scheme="cpc">C12Q2337/52</class-ref>. The definitions and scope of these Indexing Codes are self evident. The codes and definitions are listed at the end of this document.</paragraph-text><paragraph-text type="body">Due to the strong relationship between the range <class-ref scheme="cpc">C12Q1/00</class-ref> - <class-ref scheme="cpc">C12Q1/66</class-ref> and the range <class-ref scheme="cpc">G01N33/50</class-ref> - <class-ref scheme="cpc">G01N33/98</class-ref>, &quot;Chemical analysis of biological material&quot;, and the rather broad nature of the definitions of some of the <class-ref scheme="cpc">C12Q1/001</class-ref> - <class-ref scheme="cpc">C12Q1/66</class-ref> sub-groups, refinement of the classification in this area by allocation of Indexing Codes from the range <class-ref scheme="cpc">G01N2333/00</class-ref> - <class-ref scheme="cpc">G01N2800/60</class-ref>, where possible, is considered mandatory.</paragraph-text><paragraph-text type="body">Observation of the progress or of the result of processes specified in this group by any of the methods specified in groups <class-ref scheme="cpc">G01N3/00</class-ref> - <class-ref scheme="cpc">G01N29/00</class-ref> may require additional classification in these groups.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/001</classification-symbol><definition-title>{Enzyme electrodes}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Enzyme-based Electrochemical sensors where inventive concept lies in the enzyme aspect e.g. enzyme used, how attached to electrode, enzyme mediator involvement, enzyme sensing mechanism/system.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><paragraph-text type="body">Attention is drawn to the following places, which may be of interest for search and classification:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Apparatus specifically adapted for solid-phase testing in biospecific ligand binding assays or immunological testing/immunoassays</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/54366</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Involving physiochemical end-point determination</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/54373</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Electrodes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/5438</class-ref>.</paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/002</classification-symbol><definition-title>{Electrode membranes}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Enzyme electrodes where inventive concept lies in the use of or construction of a membrane on or in which an enzyme or multi-enzyme sensing system is attached or entrapped</paragraph-text></section-body></definition-statement><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Membrane</paragraph-text></table-column><table-column><paragraph-text type="body">Any non-conductive porous structure</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/003</classification-symbol><definition-title>{Functionalisation}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Inventive concept lies in chemical e.g. silylation or physical e.g. plasma treatment of the electrode membrane to alter/create functional groups for attachment of enzyme. May also include crosslinking or other treatments of membrane polymers. Overlap with <class-ref scheme="cpc">G01N33/54353</class-ref>, <class-ref scheme="cpc">G01N33/5436</class-ref>, <class-ref scheme="cpc">G01N33/54393</class-ref>.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Chemical functionalisation of solid-phases for ligand attachment for use in biospecific ligand binding assays or immunological testing/immunoassays <class-ref scheme="cpc">G01N33/54353</class-ref>.</paragraph-text><paragraph-text type="body">With the ligand physically entrapped within the solid phase <class-ref scheme="cpc">G01N33/5436</class-ref>.</paragraph-text><paragraph-text type="body">Treatment of solid-phases (e.g. coating, irradiation) for the purpose of improving reaction conditions (e.g. reduction of non-specific binding, promotion of specific binding <class-ref scheme="cpc">G01N33/54393</class-ref>.</paragraph-text></section-body></relationship></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/004</classification-symbol><definition-title>{mediator-assisted}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Enzyme electrodes where the enzyme or multi-enzyme sensing system requires a mediator e.g. co-factors (NAD/FAD), ferrodoxins.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/005</classification-symbol><definition-title>{involving specific analytes or enzymes  (including groups of enzymes, e.g. oxydases; <class-ref scheme="cpc">C12Q1/004</class-ref> takes precedence)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Enzyme electrodes directed to analysis of specific molecules or use of specific enzymes. Use of multi-enzyme systems such as oxido-reductase systems may also be classified in <class-ref scheme="cpc">C12Q1/004</class-ref> if the mediator is of importance.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/006</classification-symbol><definition-title>{for glucose}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Enzyme electrodes specifically designed for the analysis of glucose.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/007</classification-symbol><definition-title>{involving isoenzyme profiles  (for detection of an individual isoenzyme <class-ref scheme="cpc">C12Q1/25</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q1/66</class-ref>)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for determining isoenzyme profiles.Overlap with <class-ref scheme="cpc">G01N33/573</class-ref>, <class-ref scheme="cpc">G01N33/5735</class-ref>.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><paragraph-text type="body">Attention is drawn to the following places, which may be of interest for search and classification:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Biospecific ligand binding assays or immunological testing/immunoassays for isoenzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/573</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/008</classification-symbol><definition-title>{for determining co-enzymes or co-factors, e.g. NAD, ATP}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for detecting, measuring or identifying co-enzymes or co-factors e.g. NAD, ATP involved in enzyme reactions.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><paragraph-text type="body">Attention is drawn to the following places, which may be of interest for search and classification:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Biospecific ligand binding assays or immunological testing/immunoassays for co-enzymes or co-factors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/5735</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2015-03-01"><classification-symbol scheme="cpc">C12Q1/02</classification-symbol><definition-title>involving viable microorganisms</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods or processes for living microorganisms which cannot be classified elsewhere in <class-ref scheme="cpc">C12Q1/00</class-ref>- <class-ref scheme="cpc">C12Q1/66</class-ref>. Includes Total Viable Organism (TVO) testing and electrophysical measurements such as ion channel current.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/02</class-ref> and subgroups includes testing for microorganisms where the desired result indicates non-viability.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Specific binding assays/Immunoassays for microorganisms are classified in</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/569</class-ref> - <class-ref scheme="cpc">G01N33/571</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">For hepatitis</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/576</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/025</classification-symbol><definition-title>{for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics  (antimicrobial activity <class-ref scheme="cpc">C12Q1/18</class-ref>)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods or processes for testing or evaluating non antimicrobial chemical or biological compounds such as drugs, cosmetics.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Antimicrobial activity</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/18</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics, using animal cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/5008</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics, using plant cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/5097</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/04</classification-symbol><definition-title>Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(<class-ref scheme="cpc">C12Q1/6897</class-ref> takes precedence)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods or processes (qualitative testing) designed to determine the presence or identity (variety, species, genus or Gram +/-) of a microorganism, including compositions containing an indicator for presence or identity of a microorganism.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/045</classification-symbol><definition-title>{Culture media therefor}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions wherein the inventive concept lies in the composition or content of the culture media e.g. percentage ratio of components, compounds present in medium itself (carbon source, nitrogen source, vitamins etc.)</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/06</classification-symbol><definition-title>Quantitative determination</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods and processes (quantitative testing) for numerical counting the number of viable microorganisms or viable/non-viable ratio in a sample.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/08</classification-symbol><definition-title>using multifield media</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving use of a multifield media (single media permitting identification of multiple results or single item e.g. petri dish comprising more than one medium to allow multiple results) in methods and processes (quantitative testing) for numerical counting the number of viable microorganisms or viable/non-viable ratio in a sample.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/10</classification-symbol><definition-title>Enterobacteria</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving quantitative determination of Enterobacteria e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yesinia, Escherichia, Shigella, Salmonella, Klebsiella, Enterobacter, Erwinia, Hafnia.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/12</classification-symbol><definition-title>Nitrate to nitrite reducing bacteria</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving quantitative determination of bacteria under nitrate to nitrite reducing conditions. Some bacteria e.g. E.Coli use nitrate under anaerobic growth conditions.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/14</classification-symbol><definition-title>Streptococcus; Staphylococcus</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving quantitative determination of Streptococcus or Staphylococcus bacteria.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/16</classification-symbol><definition-title>using radioactive material</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions for detecting presence or kind of microorganism (qualitative testing) designed to determine the presence or identity (variety, species, genus or Gram +/-) of a microorganism. wherein the inventive concept lies in the use of radioisotopes (e.g. 11C, 13 C, 14C, 2H, 3H, 15N, 35S, 35P).</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/18</classification-symbol><definition-title>Testing for antimicrobial activity of a material</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods or processes for testing of antimicrobial activity of a compound on living microorganisms.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/20</classification-symbol><definition-title>using multifield media</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving the use of a multifield media (single media permitting identification of multiple results or single item e.g. petri dish comprising more than one medium to allow multiple results) in methods or processes for testing of antimicrobial activity of a compound on living microorganisms.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q1/22</classification-symbol><definition-title>Testing for sterility conditions</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods or processes for testing if sterility conditions have been achieved or are being maintained. Examples are labels for food packaging, testing of medical instrument sterilization methods, air or water quality.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In the following sub-groups <class-ref scheme="cpc">C12Q1/25</class-ref> - <class-ref scheme="cpc">C12Q1/66</class-ref> classification is based on the Enzyme Nomenclature as the IUB internationally agreed method.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2015-03-01"><classification-symbol scheme="cpc">C12Q1/24</classification-symbol><definition-title>Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for sampling/physically isolating intact microorganisms (including non-viable microorganisms) are classified in <class-ref scheme="cpc">C12Q1/24</class-ref> irrespective of what becomes of them afterwards. If the isolated microorganisms are further subject to immunoassay/biospecific binding assay a further symbol from <class-ref scheme="cpc">G01N33/569</class-ref> or subgroups would be added.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/25</classification-symbol><definition-title>involving enzymes not classifiable in groups <class-ref scheme="cpc">C12Q1/26</class-ref> {- <class-ref scheme="cpc">C12Q1/66</class-ref>}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes having unidentifiable EC number and enzymes which cannot be classified elsewhere in <class-ref scheme="cpc">C12Q1/26</class-ref>-<class-ref scheme="cpc">C12Q1/66</class-ref>. Classified under this symbol are methods, processes or compositions involving enzymes classified EC 6.X.X.X. These enzymes are characterised by bond formation C-O (6.1), C-S (6.2), C-N (6.3), C-C (6.4), P-O (.5), N-Met (6.6) and may commonly be known as ligase, synthase, carboxylase, cyclase, chelatase.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/26</classification-symbol><definition-title>involving oxidoreductase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 1.X.X.X oxidoreductases, not comprising as part of the IUB name &apos;dehydrogenase&apos; (see <class-ref scheme="cpc">C12Q1/32</class-ref>) and which cannot be classified elsewhere in <class-ref scheme="cpc">C12Q1/26</class-ref>-<class-ref scheme="cpc">C12Q1/32</class-ref>. Enzymes are characterised by the catalysis of oxidation/reduction reactions and may comprise as part of their IUB name reductase, oxidase, synthase, dismutase, hydrogenase, oxygenase</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/28</classification-symbol><definition-title>involving peroxidase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving peroxidase enzymes classified EC 1.11.1.X including peroxidase enzyme itself (EC 1.11.1.7).</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/30</classification-symbol><definition-title>involving catalase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving catalase enzyme, EC 1.11.1.6.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/32</classification-symbol><definition-title>involving dehydrogenase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes having an EC number 1.X.X.X and which contain &apos;dehydrogenase&apos; in the IUB standard enzyme name.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/34</classification-symbol><definition-title>involving hydrolase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 3.X.X.X hydrolases and which cannot be classified elsewhere in <class-ref scheme="cpc">C12Q1/37</class-ref>-<class-ref scheme="cpc">C12Q1/46</class-ref>. Enzymes are characterised by the catalysis of the addition or removal of a water molecule and may comprise as part of their IUB name hydrolase, lipase, lactonase, nuclease, nucleotidase, NTPase, helicase, amidase, sulfatase, depolymerase, glycosylase and variants e.g. ribonuclease. Methods, processes or compositions involving urease (EC 3.5.1.5) - <class-ref scheme="cpc">C12Q1/58</class-ref>. Methods, processes or compositions involving (phospho)lipase - <class-ref scheme="cpc">C12Q1/61</class-ref>.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/37</classification-symbol><definition-title>involving peptidase or proteinase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 3.4.X.X. The enzymes are classified as acting on peptide bonds and may comprise as part of the IUB name peptidase and variants e.g. dipeptidase, aminopeptidase. Methods, processes or compositions involving clotting factors - <class-ref scheme="cpc">C12Q1/56</class-ref>.</paragraph-text><paragraph-text type="body">There are many enzymes classified in the area EC 3.4.21.X - 3.4.23.X which retain the &apos;original&apos; names e.g. trypsin, complement factors, kallikrein, subtilisin, papain, Meprin A, renin.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/40</classification-symbol><definition-title>involving amylase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 3.2.1.X. Enzymes are characterised by hydrolysis of O - and S -glycosyl compounds and may comprise as part of the IUB name (sugar residue)sidase e.g. galactosidase, mannosidase.</paragraph-text><paragraph-text type="body">There are many enzymes classified in the area EC 3.2.1.X which retain the &apos;original&apos; names e.g. amylase, lysozyme, lactase.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/42</classification-symbol><definition-title>involving phosphatase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 3.1.3.X. Enzymes are characterised by hydrolysis of phosphoric monoesters and usually comprise as part of the IUB name phosphatase.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/44</classification-symbol><definition-title>involving esterase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 3.1.X.X having as part of the IUB name &apos;esterase&apos; or variant e.g. diesterase, thioesterase. Enzymes are characterised by acting on ester bonds.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/46</classification-symbol><definition-title>involving cholinesterase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving acetylcholinesterase, EC 3.1.1.7 or cholinesterase EC 3.1.1.8.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/48</classification-symbol><definition-title>involving transferase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 2.X.X.X transferases and which cannot be classified elsewhere in <class-ref scheme="cpc">C12Q1/485</class-ref>-<class-ref scheme="cpc">C12Q1/52</class-ref>. Enzymes are characterised by the transfer of a functional group and may comprise as part of their IUB name kinase, transferase, synthase, phosphorylase and variants e.g. aminotransferase.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/485</classification-symbol><definition-title>{involving kinase}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 2.7.X.X having as part of the IUB name &apos;kinase&apos; or variant. Enzymes are characterised by the transfer of phosphorus-containing groups.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/50</classification-symbol><definition-title>involving creatine phosphokinase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzyme creatine (phospho)kinase, EC 2.7.3.2.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/52</classification-symbol><definition-title>involving transaminase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 2.6.1.X and may comprise as part of the IUB name &apos;transaminase&apos;. Enzymes are characterised by the transfer of nitrogenous groups.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/527</classification-symbol><definition-title>involving lyase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 4.X.X.X lyases and may comprise as part of the IUB name lyase, carboxylase, aldolase, hydratase and variants e.g. decarboxylase, dehydratase. Enzymes are characterised by the catalysis of reactions involving the formation of or addition to a double bond.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/533</classification-symbol><definition-title>involving isomerase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving enzymes classified as EC 5.X.X.X isomerases and may comprise as part of the IUB name racemase, mutase, epimerase, isomerase, tautomerase, synthase and variants e.g. aminomutase. Enzymes are characterised by the catalysis of isomerisation reactions.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The sub-groups <class-ref scheme="cpc">C12Q1/54</class-ref> - <class-ref scheme="cpc">C12Q1/66</class-ref> are intended to highlight specific subject-matter which might also take an earlier symbol. The sub-groups <class-ref scheme="cpc">C12Q1/54</class-ref> - <class-ref scheme="cpc">C12Q1/66</class-ref> take precedence over earlier sub-groups under the Last Place Rule.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/54</classification-symbol><definition-title>involving glucose or galactose</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving glucose or galactose where glucose or galactose are the final analyte or subject of the test e.g. diabetes testing, glucose demand for testing presence of microorganisms, Glucose Tolerance Test, use of glucose or galactose in the production of enzymes. Electrochemical glucose sensors where the inventive concept is in an electrode or other sensor structure to specifically enhance glucose determinations are classified in <class-ref scheme="cpc">C12Q1/006</class-ref>.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/56</classification-symbol><definition-title>involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving blood clotting factors e.g. thrombin, fibrinogen, thromboplastin. Includes investigation and/or identification of compounds which are present in or modulate the clotting pathway.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/58</classification-symbol><definition-title>involving urea or urease</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving detection of urea or urease (EC 3.5.1.5). Includes measurement of Biological Nitrogen Demand. Urea electrodes where the inventive concept is in the electrode are classified in <class-ref scheme="cpc">C12Q1/001</class-ref> - <class-ref scheme="cpc">C12Q1/005</class-ref>. Includes detection of ammonia.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/60</classification-symbol><definition-title>involving cholesterol</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving detection of cholesterol or LDL-cholesterol. Cholesterol electrodes where the inventive concept is in the electrode are classified in <class-ref scheme="cpc">C12Q1/005</class-ref>.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Overlap with <class-ref scheme="cpc">G01N33/92</class-ref>.</paragraph-text></section-body></relationship></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/61</classification-symbol><definition-title>involving triglycerides</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving detection of triglycerides, e.g. as biomarkers for disease, HDL, LDL, CM values or acting as substrate for determination of (phospho)lipase enzymes.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Overlap with <class-ref scheme="cpc">G01N33/92</class-ref>.</paragraph-text></section-body></relationship></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/62</classification-symbol><definition-title>involving uric acid</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving detection of uric acid, often using the enzyme uricase (EC 1.7.3.3). Includes detection of uric acid as breakdown product indicative of other analytes e.g. purine bases, nucleotides.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12Q1/64</classification-symbol><definition-title>Geomicrobiological testing, e.g. for petroleum</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving detection of microbiological degradation or contamination of in-situ hydrocarbon reserves, hydrocarbon reserve prospecting using microorganisms, monitoring of microorganism contamination of liquid hydrocarbon fuels, carbon dioxide sequestering by subterranean microorganism methane production.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/66</classification-symbol><definition-title>involving luciferase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods, processes or compositions involving luciferase (EC 1.13.12.X or EC 1.14.14.3).</paragraph-text></section-body></definition-statement></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/68</classification-symbol><definition-title>involving nucleic acids</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All documents which cannot be classified in any of the other groups but relate to the enzymatic manipulation of nucleic acids.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Group <class-ref scheme="cpc">C12Q1/00</class-ref>&#160;relates to enzymes. From&#160;group <class-ref scheme="cpc">C12Q1/68</class-ref>&#160;onwards, assays and products for analysing or detecting nucleic acids are covered irrespective of whether enzymes or microorganisms are involved. Group <class-ref scheme="cpc">C12Q1/70</class-ref>&#160;similarly relates to nucleic acid assays and products for analysing or detecting viruses or bacteriophages.</paragraph-text><paragraph-text type="body">Nucleic acid amplification reactions are classified in&#160;group <class-ref scheme="cpc">C12P19/34</class-ref>&#160;if the focus of the subject-matter is on the enzymes or the enzyme modifications per se. However, if the enzyme modification results in a changed/improved analytical effect, classification is also effected in&#160;group <class-ref scheme="cpc">C12Q1/68</class-ref>.</paragraph-text></section-body></relationship><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Immunization, vaccines</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Viral antigens in a vaccine</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/12</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Gene therapy</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Design and fabrication of microarrays (biochips) wherein the invention resides in the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01J19/0046</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microfluidic systems used for nucleic acid analysis like thermal cyclers (PCR-machines), capillary sequencers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01L1/00</class-ref>- <class-ref scheme="cpc">B01L99/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical synthesis or modification of nucleosides, nucleotides or oligonucleotides (chemically linked to other compounds, fluorescent labels).</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref>- <class-ref scheme="cpc">C07H21/04</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bacterial, fungal, protozoal, vertebrate antigens.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref> - <class-ref scheme="cpc">C07K14/825</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Undifferentiated human, animal or plant cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Plant cells </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/04</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Animal cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/06</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cells modified by introduction of foreign genetic material </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Viruses; Bacteriophages</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N7/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bacterial, fungal and protozoan enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Extraction and purification of nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefore</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Isolating individual clones by screening libraries; making libraries</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1034</class-ref> - <class-ref scheme="cpc">C12N15/1093</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">DNA or RNA fragments; Modified forms thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/11</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/63</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bacterial vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/70</class-ref> -<class-ref scheme="cpc">C12N15/78</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Vectors for fungal cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/80</class-ref> - <class-ref scheme="cpc">C12N15/815</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/8201</class-ref>- <class-ref scheme="cpc">C12N15/8214</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Animal vectors and their preparation</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/85</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Sensors and electronic devices involving nucleic acids wherein the electrical detection is important</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N27/00</class-ref>, <class-ref scheme="cpc">G01N31/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Sensors and electronic devices wherein the optical detection is important</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N31/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Protein diagnostics and detection</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Coulter counters</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N35/00</class-ref>- <class-ref scheme="cpc">G01N35/1097</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Computer systems using nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G11C13/0019</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bioinformatics</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G16B</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In groups <class-ref scheme="cpc">C12Q1/68</class-ref> - <class-ref scheme="cpc">C12Q1/708</class-ref>, the common rule is applied, i.e. the classification is made at the most appropriate place.</paragraph-text><paragraph-text type="subheading">Classification guidance</paragraph-text><paragraph-text type="body">The subgroups&#160;<class-ref scheme="cpc">C12Q1/68</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q1/708</class-ref>&#160;are divided in method groups and nucleic acid product groups (primers, probes, arrays, and other nucleic acid products) as shown in the tables below. </paragraph-text><paragraph-text type="body">Depending on which kind of subject matter of invention is being classified (i.e. method or product), different rules for classification apply. </paragraph-text><paragraph-text type="body">If the methods disclosed by an application are known or trivial, classification of such trivial methods is determined based on the use of the products identified and follows the classification guidance for products. </paragraph-text><paragraph-text type="body">Orthogonal Indexing symbols <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref> are used with the CPC method groups.</paragraph-text><paragraph-text type="body">Orthogonal Indexing symbols of the groups <class-ref scheme="cpc">C12Q2600/00</class-ref> - <class-ref scheme="cpc">C12Q2600/178</class-ref> are used with the CPC product groups.</paragraph-text><paragraph-text type="body"><media id="media0.png" file-name="cpc-def-C12Q-0000.png" type="png" preferred-width="12.04cm" preferred-height="4.93cm"/></paragraph-text><paragraph-text type="subheading">Classification of Nucleic acid product groups and trivial methods:</paragraph-text><paragraph-text type="body">Nucleic acid product groups are shown below:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Symbol</paragraph-text></table-column><table-column><paragraph-text type="body">Title</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6876</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Hybridisation probes, primers, and other nucleic acid products</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6879</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For sex determination</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6881</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For tissue and cell typing, e.g. hla probes </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6883</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For diseases caused by alterations of genetic material </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6886</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For cancer </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6888</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For detection or identification of organisms </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/689</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For bacteria </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6893</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For protozoa </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6895</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For plants, fungi, or algae </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/701</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Specific hybridisation probes </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/702</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For retroviruses </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/703</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Viruses associated with AIDS </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/705</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For herpetoviridae, e.g. herpes simplex, varicella zoster </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/706</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For hepatitis </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/707</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Non-A, non-B Hepatitis, excluding hepatitis D </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/708</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For papilloma </paragraph-text></table-column></table-row></table><paragraph-text type="body">Classification guidance for nucleic acid products and trivial methods:</paragraph-text><list><list-item><paragraph-text type="body">The nucleic acid product groups <class-ref scheme="cpc">C12Q1/6876</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q1/6895</class-ref> and <class-ref scheme="cpc">C12Q1/701</class-ref>- <class-ref scheme="cpc">C12Q1/708</class-ref>&#160;are allocated as single symbols in conjunction with orthogonal Indexing symbols of the groups <class-ref scheme="cpc">C12Q2600/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q2600/178</class-ref>. </paragraph-text></list-item><list-item><paragraph-text type="body">The&#160;<class-ref scheme="cpc">C12Q2600/00</class-ref>&#160;orthogonal Indexing symbols are given as independent symbols. </paragraph-text></list-item><list-item><paragraph-text type="body">The use of the&#160;<class-ref scheme="cpc">C12Q2600/00</class-ref>&#160;codes is compulsory. They should be given if the claims and/or examples support a functional use as given by any of the&#160;<class-ref scheme="cpc">C12Q2600/00</class-ref>&#160;symbols as shown above.</paragraph-text></list-item></list><paragraph-text type="subheading">Examples for nucleic acid product groups:</paragraph-text><paragraph-text type="body">Example 1. An invention is directed to the identification of the TNF haplotype TNF-1031C/-857C/-863C/-308G and its association with Crohn&apos;s Disease. The disclosure provides data showing a significant association of the haplotype with the Crohn&apos;s Disease. The invention also relates to the identification of the -857C allele. The methods and means for determining these polymorphisms and haplotypes are known in the art, therefore considered as trivial.</paragraph-text><paragraph-text type="body">The nucleic acid product symbol for this invention is&#160;<class-ref scheme="cpc">C12Q1/6883</class-ref>.</paragraph-text><paragraph-text type="body">Although the method for determining the -857C polymorphism is known, adding the orthogonal indexing symbol&#160;<class-ref scheme="cpc">C12Q2600/156</class-ref>&#160;(polymorphic or mutational markers) will help in retrieving the information about use of the identified polymorphic allele, like 857C, and its association with Crohn&apos;s Disease.</paragraph-text><paragraph-text type="body">The method for determining the haplotype is known. However, adding the orthogonal indexing symbol <class-ref scheme="cpc">C12Q2600/172</class-ref> (Haplotypes) will aid in retrieving the information about use of haplotypes, like TNF-1031C/-857C/-863C/-308G, and its association with Crohn&apos;s Disease.</paragraph-text><paragraph-text type="body">The complete classification should therefore be <class-ref scheme="cpc">C12Q1/6883</class-ref>, <class-ref scheme="cpc">C12Q2600/156</class-ref> and <class-ref scheme="cpc">C12Q2600/172</class-ref>.</paragraph-text><paragraph-text type="body">Example 2. An application relates to the use of the B1153 gene in testing for an allergic disease. The expression level of this gene is increased in patients with an allergic disease. The methods and means for determining the expression level are trivial. </paragraph-text><paragraph-text type="body">The nucleic acid product symbol for this application is&#160;<class-ref scheme="cpc">C12Q1/6883</class-ref>.</paragraph-text><paragraph-text type="body">The methods for determining the expression level are trivial but adding the orthogonal indexing symbol&#160;<class-ref scheme="cpc">C12Q2600/158</class-ref>&#160;(expression marker) will aid in retrieving the information of use of specific expression markers, including B1153.</paragraph-text><paragraph-text type="body">The complete classification should therefore be <class-ref scheme="cpc">C12Q1/6883</class-ref> and <class-ref scheme="cpc">C12Q2600/158</class-ref>.</paragraph-text><paragraph-text type="body">Example 3. An application relates to the use of a SNP for determining if a patient would benefit from an anti-cancer therapy. The methods and means for determining the SNP are trivial.</paragraph-text><paragraph-text type="body">The nucleic acid product symbol for this application would be&#160;<class-ref scheme="cpc">C12Q1/6886</class-ref>.</paragraph-text><paragraph-text type="body">The methods for determining the SNP are trivial but adding the orthogonal indexing symbol <class-ref scheme="cpc">C12Q2600/156</class-ref>&#160;(polymorphic or mutational markers) will aid in retrieving information about polymorphic or mutational markers.</paragraph-text><paragraph-text type="body">In addition, the application claims pharmacogenomics. If the application provides evidence-based support (e.g. examples) for this claim, orthogonal indexing symbol <class-ref scheme="cpc">C12Q2600/106</class-ref>&#160;is also given. If no support is present, only the Indexing symbol for polymorphic marker <class-ref scheme="cpc">C12Q2600/156</class-ref>&#160;is given.</paragraph-text><paragraph-text type="body">The complete classification should therefore be:</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6886</class-ref> and <class-ref scheme="cpc">C12Q2600/156</class-ref> if no support is present, or</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6886</class-ref>, <class-ref scheme="cpc">C12Q2600/106</class-ref> and <class-ref scheme="cpc">C12Q2600/156</class-ref> if the application provides support for a pharmacogenomics claim.</paragraph-text></list-item></list><paragraph-text type="subheading">Classification of non-invention information (additional information):</paragraph-text><paragraph-text type="body">All subgroups in <class-ref scheme="cpc">C12Q1/68</class-ref> - <class-ref scheme="cpc">C12Q1/708</class-ref> can be used for classifying non-invention information (or Additional information) that compliments Invention information and is useful for searches. Such Additional information is given under the classifier&apos;s discretion. The following example illustrates how to classify non-invention information as (A) that is useful for search:</paragraph-text><paragraph-text type="body">Example: An application relates to oligonucleotide probes used for the species-specific identification of parodontophathogenic bacteria by in situ hybridisation. The methods for performing the in situ hybridisation are known in the art and considered as non-invention.</paragraph-text><paragraph-text type="body">The application is given <class-ref scheme="cpc">C12Q1/689</class-ref>&#160;for the bacterial detection probes as Inventive information.</paragraph-text><paragraph-text type="body">Although the method in situ hybridisation is known in the art, adding <class-ref scheme="cpc">C12Q1/6841</class-ref>&#160;(in situ hybridisation) as Additional information will aid in retrieving the method of identifying novel bacteria by using in situ hybridisation.</paragraph-text><paragraph-text type="body">In searching, the combination of&#160;<class-ref scheme="cpc">C12Q1/689</class-ref> (Inventive information (I)), <class-ref scheme="cpc">C12Q1/6841</class-ref>(Additional information (A)), and keywords will directly lead to the most relevant documents.</paragraph-text><paragraph-text type="body">The complete classification should therefore be: </paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/689</class-ref> (I) </paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6841</class-ref>(A)</paragraph-text></list-item></list><paragraph-text type="subheading">Classification of methods groups as invention information:</paragraph-text><paragraph-text type="body">Within <class-ref scheme="cpc">C12Q1/68</class-ref> - <class-ref scheme="cpc">C12Q1/6874</class-ref> and <class-ref scheme="cpc">C12Q1/6897</class-ref> - <class-ref scheme="cpc">C12Q1/70</class-ref>, the following subgroups listed in table below are considered as method groups related to nucleic acids. </paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Symbol</paragraph-text></table-column><table-column><paragraph-text type="body">Title</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6804</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid analysis utilising immunogens </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6806</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Preparing nucleic acids for analysis, e.g. for PCR assay </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6809</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Sequence identification involving differential detection</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6811</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Selection methods for production or design of target specific oligonucleotide or binding molecules </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6813</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Hybridisation assays </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6816</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Characterised by the means of detection </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6818</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Involving interaction of at least two labels, e.g. resonant energy transfer </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/682</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Signal amplification </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6823</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Release of bound marker </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6825</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid detection involving sensors </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6827</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">For mutation or polymorphism detection </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/683</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Involving restriction enzymes, e.g. rflp </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6832</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Enhancement of hybridisation reaction </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6834</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid analysis involving immobilisation; Immobilisation characterised by the carrier or coupling agent </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6837</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Characterised by the use of probe arrays or probe chips </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6839</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Triple helix formation in hybridisation assays </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6841</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">In situ hybridisation </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6844</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid amplification reactions </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6846</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Common amplification features </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6848</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Preventing contamination </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6851</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Quantitative amplification </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6853</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Using modified primers or templates </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6855</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Ligating adaptors </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6858</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Allele specific amplification </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/686</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Polymerase chain reaction [PCR] </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6862</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Ligase chain reaction [LCR]</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6865</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Promoter based amplification, e.g. NASBA, 3SR, TAS </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6867</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Replicase based amplifications, e.g. Q-beta replicase </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6869</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Methods for sequencing; sequencing using nanopores and other sequencing systems based on physical properties of nucleic acids, e.g. Atomic Force Microscopy [AFM]</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6872</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Involving mass spectrometry </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6874</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Involving nucleic acid arrays, e.g. sequencing by hybridisation [SBH] </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6897</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Involving reporter genes operably linked to promoters</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/70</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">Involving viruses and Bacteriophages</paragraph-text></table-column></table-row></table><paragraph-text type="subheading">Combination sets (C-Sets): </paragraph-text><paragraph-text type="body">Methods related to nucleic acids as listed above in the table are classified in the form of C-Sets, which follows C-Sets rule #C12Qa as described in below.</paragraph-text><paragraph-text type="subheading">C-Sets statement: #C12Qa</paragraph-text><list><list-item><paragraph-text type="body">In these C-Sets, the base symbol, representing the type of method are taken from the groups <class-ref scheme="cpc">C12Q1/68</class-ref> - <class-ref scheme="cpc">C12Q1/6874</class-ref>, <class-ref scheme="cpc">C12Q1/6897</class-ref> and <class-ref scheme="cpc">C12Q1/70</class-ref>, whereas the subsequent symbols representing the essential technical features of the method are taken from the orthogonal symbols <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Orthogonal symbols <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref> are only used as subsequent symbols in C-Sets and should not be allocated as single symbol.</paragraph-text></list-item><list-item><paragraph-text type="body">In the C-Set, only the essential technical features of the invention, which differentiate it from the prior art, are to be represented: only exceptionally more than three technical feature (orthogonal symbols) codes should make up the C-Set. The least possible number of orthogonal symbols should be included in the C-Set.</paragraph-text></list-item><list-item><paragraph-text type="body">All indexing codes from groups&#160;<class-ref scheme="cpc">C12Q2500/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q2565/634</class-ref>&#160;are to be used in the context literally expressed in the phrase ascribed to the code, i.e. the use of an indexing code is neither restricted by its hierarchical position in a group nor by the definition of the group in which the code is found.</paragraph-text></list-item><list-item><paragraph-text type="body">All C-Sets #C12Qa should be allocated as Invention information (INV).</paragraph-text></list-item></list><paragraph-text type="subheading">C-Sets syntax rules:</paragraph-text><list><list-item><paragraph-text type="body">Each C-Set shall contain two or more symbols. Each C-Set shall contain one base symbol from <class-ref scheme="cpc">C12Q1/68</class-ref>, <class-ref scheme="cpc">C12Q1/6804</class-ref> - <class-ref scheme="cpc">C12Q1/6874</class-ref>, <class-ref scheme="cpc">C12Q1/6897</class-ref> and <class-ref scheme="cpc">C12Q1/70</class-ref>, and at least one subsequent symbol from <class-ref scheme="cpc">C12Q2500/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q2565/634</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Duplicate symbols are not allowed in these C-Sets. </paragraph-text></list-item><list-item><paragraph-text type="body">The order of the subsequent symbols in these C-Sets is not relevant.</paragraph-text></list-item></list><paragraph-text type="subheading">C-Sets examples:</paragraph-text><paragraph-text type="body">#C12Qa: Nanopore sequencing is accomplished by measuring changes to an electrical current as a nucleic molecule is passed through a pore. An application discloses an improved method of nanopore sequencing using an immobilized helicase at the pore entrance:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6869</class-ref> is given as a base symbol for the method of sequencing </paragraph-text><paragraph-text type="body">The essential technical features of the inventive method are assigned using orthogonal indexing codes as follows:</paragraph-text><list><list-item><paragraph-text type="body">Feature 1: <class-ref scheme="cpc">C12Q2565/631</class-ref> being a biochannel or pore</paragraph-text></list-item><list-item><paragraph-text type="body">Feature 2: <class-ref scheme="cpc">C12Q2521/543</class-ref> immobilized enzyme(s) </paragraph-text></list-item><list-item><paragraph-text type="body">Feature 3: <class-ref scheme="cpc">C12Q2521/513</class-ref> winding/unwinding enzyme, e.g. helicase</paragraph-text></list-item></list><paragraph-text type="body">These orthogonal indexing codes are selected to describe the essential technical features of the method, and not to capture all features of the method of nanopore sequencing, such as <class-ref scheme="cpc">C12Q2565/607</class-ref> being a sensor, e.g. electrode.</paragraph-text><paragraph-text type="body">Complete C-set: (<class-ref scheme="cpc">C12Q1/6869</class-ref>, <class-ref scheme="cpc">C12Q2521/513</class-ref>, <class-ref scheme="cpc">C12Q2521/543</class-ref>, <class-ref scheme="cpc">C12Q2565/631</class-ref>)</paragraph-text><paragraph-text type="body">#C12Qa: An application discloses an inventive method of nucleic acid quantification using an amplification method with an external standard and a logarithmic regression for determining the initial amount of nucleic acid present: </paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6851</class-ref> is given as a base symbol for the method of quantitative amplification </paragraph-text><paragraph-text type="body">The following orthogonal indexing codes in <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref> are assigned for the essential technical features of the inventive method: </paragraph-text><list><list-item><paragraph-text type="body">Feature 1: <class-ref scheme="cpc">C12Q2545/113</class-ref> with an external standard/control</paragraph-text></list-item><list-item><paragraph-text type="body">Feature 2: <class-ref scheme="cpc">C12Q2537/165</class-ref> Mathematical modelling</paragraph-text></list-item></list><paragraph-text type="body">Complete C-set: (<class-ref scheme="cpc">C12Q1/6851</class-ref>, <class-ref scheme="cpc">C12Q2537/165</class-ref>, <class-ref scheme="cpc">C12Q2545/113</class-ref>)</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6804</classification-symbol><definition-title>Nucleic acid analysis using immunogens  (immunoassay <class-ref scheme="cpc">G01N33/53</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Applications characterised by immunological compounds which are used in the analysis of nucleic acids. This group also includes applications characterised by nucleic acids which are used for analysing or detecting proteins and immunogens, e.g. immuno PCR).</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Immunoassay</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/53</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay for nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/5308</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Antibodies</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Immunogens</paragraph-text></table-column><table-column><paragraph-text type="body">means immunological compounds such as antibodies and antigens</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6806</classification-symbol><definition-title>Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay  (<class-ref scheme="cpc">C12Q1/6804</class-ref> takes precedence)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications which deal with the preparation/modification of nucleic acids in order to use them or prepare them for subsequent analysis (e.g. amplification techniques (PCR), hybridisation techniques, sequencing of nucleic acids). This group also contains applications dealing with the preservation of DNA or RNA samples.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefore</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1003</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Extracting or separating nucleic acids from biological samples by means of a solid support carrier, e.g. particles, polymers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1006</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Extracting or separating nucleic acids from biological samples by chromatography, e.g. electrophoresis, ion-exchange, reverse phase</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/101</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Extracting or separating nucleic acids from biological samples by using magnetic beads</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1013</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Extracting or separating nucleic acids from biological samples by filtration, e.g. using filters, frits, membranes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1017</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6809</classification-symbol><definition-title>Methods for determination or identification of nucleic acids involving differential detection</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All documents where the invention concerns a method for determining differential expression (RNA level) and comparative genomics (genomic DNA level) and improvements to such methods. However, if the methods disclosed by an application are known, these applications are classified as products based on the use of the products identified.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">The screening and making of libraries (e.g. cDNA libraries)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1072</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6811</classification-symbol><definition-title>Selection methods for production or design of target specific oligonucleotides or binding molecules</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">The design of primers and probes using enzymatic techniques for obtaining them.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Isolating an individual clone by screening libraries</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1034</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1037</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Ribosome/Polysome display, e.g. SPERT, ARM</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1041</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation or screening of libraries displayed on scaffold proteins</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1044</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">SELEX</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1048</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1051</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Protein x Protein interaction, e.g. two hybrid selection</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1055</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1058</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">mRNA-Display, e.g. polypeptide and encoding template are connected covalently</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1062</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1065</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis (NRPS), DNA/RNA-polymerase mediated polypeptide synthesis</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1068</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Differential gene expression library synthesis, e.g. subtracted libraries, differential screening</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1072</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">By coupling phenotype to genotype, not provided for in other groups of this group</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1075</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Screening libraries by altering the phenotype or phenotypic trait of the host </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1079</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1082</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation or screening of expression libraries, e.g. reporter assays</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1086</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Design, preparation, screening or analysis of libraries using computer algorithms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1089</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">General methods of preparing gene libraries, not provided for in other subgroups</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1093</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Phage display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bioinformatics for probe design or probe optimization</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G16B25/20</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6813</classification-symbol><definition-title>Hybridisation assays</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with hybridisation assays which can not be classified in any of the hybridisation subgroups.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6816</classification-symbol><definition-title>characterised by the detection means  (<class-ref scheme="cpc">C12Q1/6804</class-ref> takes precedence)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Applications dealing with the detection of hybridisation assays characterised by the detection means.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Means of detection</paragraph-text></table-column><table-column><paragraph-text type="body">the mechanism used to detect the hybridisation of a nucleic acid probe to its nucleic acid target (e.g. labels,...)</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6818</classification-symbol><definition-title>involving interaction of two or more labels, e.g. resonant energy transfer</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with the detection of hybridisation events using the interaction between the labels as principle.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">The use of this detection principle in non-hybridisation based techniques such as nucleic acid amplification in group <class-ref scheme="cpc">C12Q1/6844</class-ref> or sequencing in group <class-ref scheme="cpc">C12Q1/6869</class-ref> are not covered by <class-ref scheme="cpc">C12Q1/6818</class-ref> unless the invention resides in an improvement which has general applicability also for hybridisation assays (for instance an improved Taqman probe). In this case, both <class-ref scheme="cpc">C12Q1/6818</class-ref> and an amplification or sequencing group can be given. </paragraph-text></section-body></relationship><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/682</classification-symbol><definition-title>Signal amplification</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications where the detection signal generated in a hybridisation reaction is amplified (for instance the use of branched probes or rolling circle amplification to amplify the hybridisation signal).</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Amplification of target nucleic acids as such wherein the target amplification results in an increase of signal which is not seen as signal amplification and is not classified in <class-ref scheme="cpc">C12Q1/682</class-ref>. </paragraph-text><paragraph-text type="body">Electronic signal amplification is not classified in group <class-ref scheme="cpc">C12Q1/682</class-ref> .</paragraph-text></section-body></relationship><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-02-01"><classification-symbol scheme="cpc">C12Q1/6823</classification-symbol><definition-title>Release of bound markers</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications wherein the hybridisation detection depends on the physical separation and subsequent detection of a signalling moiety.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">The use of this detection principle in non-hybridisation based techniques such as nucleic acid amplification in group <class-ref scheme="cpc">C12Q1/6844</class-ref> or sequencing in group <class-ref scheme="cpc">C12Q1/6869</class-ref> are not covered by group <class-ref scheme="cpc">C12Q1/6823</class-ref> unless the invention resides in an improvement which has general applicability also for hybridisation assays. In this case both <class-ref scheme="cpc">C12Q1/6823</class-ref> and an amplification or sequencing group can be given. </paragraph-text></section-body></relationship></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6825</classification-symbol><definition-title>Nucleic acid detection involving sensors</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications wherein the detection of the hybridisation reaction depends on the electrical or physical properties of the label or of the nucleic acid molecules themselves.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Sensors wherein the optical detection is important</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Sensors and electronic devices involving nucleic acids wherein the electrical detection is important</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N27/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6827</classification-symbol><definition-title>for detection of mutation or polymorphism</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All methods dealing with the detection of polymorphisms using an hybridisation assay and which cannot be classified in&#160;group <class-ref scheme="cpc">C12Q1/683</class-ref>. The detection of methylation and splice variants is seen as polymorphism detection and therefore classified in this group if the detection principle is based on an hybridisation assay.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">The detection of polymorphisms using amplification based techniques is classified in&#160;group <class-ref scheme="cpc">C12Q1/6858</class-ref>. The use of allele specific primer extension is covered by group <class-ref scheme="cpc">C12Q1/6858</class-ref>&#160;and not <class-ref scheme="cpc">C12Q1/6827</class-ref>.</paragraph-text><paragraph-text type="body">See the &quot;Special rules&quot; section of&#160;<class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></relationship><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Sequence identification involving differential detection</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6809</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Allele specific amplification; The detection of polymorphisms using amplification based techniques</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6858</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6832</classification-symbol><definition-title>Enhancement of hybridisation reaction</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with the enhancement of the binding between a target and its probe, e.g. use of special buffer components, temperatures, probe modifications.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Sequence identification involving differential detection</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6809</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Increasing the specificity or sensitivity of an amplification reaction</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6848</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Allele specific amplification</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6858</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6834</classification-symbol><definition-title>Enzymatic or biochemical coupling of nucleic acids to a solid phase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with the enzymatic and biochemical coupling of nucleic acids to solid surfaces for the use in low throughput assays and the application of those solid surfaces in the subsequent analysis of a nucleic acid.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Design and fabrication of microarrays (biochips) wherein the invention resides in the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01J19/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical synthesis or modification of nucleosides, nucleotides or oligonucleotides, chemically linked to other compounds (fluorescent labels)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref>-<class-ref scheme="cpc">C07H21/04</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6837</classification-symbol><definition-title>using probe arrays or probe chips  (<class-ref scheme="cpc">C12Q1/6874</class-ref> takes precedence)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All nucleic acid analysis methods which depend on the use of probe arrays (biochips, microarray). If the use of the array is in the context of a method which can be classified in another group of the hybridisation based assays, e.g.&#160;<class-ref scheme="cpc">C12Q1/6813</class-ref>, the classifier has to decide based on the relevance of the method to classify the application in either one of these groups or even to classify the application in both groups if necessary. However, if the use is for sequencing then the application is only classified in group <class-ref scheme="cpc">C12Q1/6874</class-ref>.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Involving nucleic acid arrays, e.g. sequencing by hybridisation [SBH]</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6874</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Design and fabrication of microarrays (biochips) wherein the invention resides in the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01J19/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical synthesis or modification of nucleosides, nucleotides or oligonucleotides, chemically linked to other compounds (fluorescent labels)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref>-<class-ref scheme="cpc">C07H21/04</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6839</classification-symbol><definition-title>Triple helix formation or other higher order conformations in hybridisation assays</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All methods dealing with the formation of a triple helix DNA conformation. This group also covers other higher order conformations of nucleic acids (quadruplex).</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6841</classification-symbol><definition-title>In situ hybridisation</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with methods for the analysis of a nucleic acid in a cell or positionally in a chromosome like Fluorescent In Situ Hybridisation [FISH].</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6844</classification-symbol><definition-title>Nucleic acid amplification reactions</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All amplification methods which do not belong in any of the amplification groups. Generally, amplification techniques which use a mechanism for amplifying nucleic acids and for which no group exists are classified in group <class-ref scheme="cpc">C12Q1/6844</class-ref>. An example of such an amplification technique is strand displacement amplification [SDA].</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microfluidic systems used for nucleic acid analysis like thermal cyclers (PCR-machines), capillary sequencers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01L1/00</class-ref> - <class-ref scheme="cpc">B01L99/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical synthesis of oligonucleotides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6848</classification-symbol><definition-title>characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for preventing contamination in an amplification reaction such as the use of wax barriers, containers, uracil glycosylase, hot start and nested PCR. In addition, all methods relating to increasing the specificity or sensitivity of an amplification reaction are classified in this group.</paragraph-text><paragraph-text type="body">This group also covers means for reducing false positive or false negative signals in an amplification reaction.</paragraph-text><paragraph-text type="body">These include the use of modified nucleotides, e.g. in amplification reactions designed for amplifying GC-rich templates, special buffer components, pH, reaction conditions, etc. </paragraph-text><paragraph-text type="body">If the method is designed for a specific amplification technique like PCR in group <class-ref scheme="cpc">C12Q1/686</class-ref>, then it is both classified in the specific amplification group, i.e. <class-ref scheme="cpc">C12Q1/686</class-ref>, and in <class-ref scheme="cpc">C12Q1/6848</class-ref>.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Methods for preventing contamination before an amplification reaction</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6806</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enhancement of hybridisation reactions</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6832</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6851</classification-symbol><definition-title>Quantitative amplification</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for the quantitative amplification of nucleic acids including the use of standards or mathematical models. This group also covers methods (both again enzymatic and mathematical) for determining the amplification efficiency.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G16B25/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6853</classification-symbol><definition-title>using modified primers or templates</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods using modified primers or templates.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6855</classification-symbol><definition-title>Ligating adaptors</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods where the primer or the template is modified by the ligation to an adaptor.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6858</classification-symbol><definition-title>Allele-specific amplification</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All methods dealing with the detection of polymorphisms using an amplification assay. The detection of methylation and splice variants is seen as polymorphism detection and therefore classified in this group if the detection principle is based on an amplification assay. This includes allele specific primer extension (also when only one dNTP or ddNTP is incorporated using a polymerase).</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Hybridisation based polymorphism detection</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6827</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Hybridisation based polymorphism detection involving restriction enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/683</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Sequencing</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6869</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/686</classification-symbol><definition-title>Polymerase chain reaction [PCR]</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with PCR and modifications/improvements thereof (e.g. Taqman, multiplex-PCR, and etc.).</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6862</classification-symbol><definition-title>Ligase chain reaction [LCR]</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with LCR and modifications/improvements thereof.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6865</classification-symbol><definition-title>Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with promoter based amplification and modifications/improvements thereof.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">NASBA</paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid sequence based amplification </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">3SR</paragraph-text></table-column><table-column><paragraph-text type="body">selfsustained sequence replication</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">TAS</paragraph-text></table-column><table-column><paragraph-text type="body">transcription-based amplification system</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6867</classification-symbol><definition-title>Replicase-based amplification, e.g. using Q-beta replicase</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with replicase based amplifications and modifications/improvements thereof.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6869</classification-symbol><definition-title>Methods for sequencing</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All nucleic acid sequencing methods which cannot be classified in the subgroups for sequencing using mass spectrometry, i.e. in group <class-ref scheme="cpc">C12Q1/6872</class-ref> and sequencing using solid surfaces, i.e. in group <class-ref scheme="cpc">C12Q1/6874</class-ref>. This group also covers methods for sequencing using nanopores and other sequencing systems based on physical properties of nucleic acids, e.g. Atomic Force Microscopy [AFM].</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Allele specific primer extension</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6858</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microfluidic systems used for nucleic acid analysis like thermal cyclers (PCR-machines), capillary sequencers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01L1/00</class-ref>-<class-ref scheme="cpc">B01L99/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Apparatus for sequencing using nanopores or nanochannels</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/48721</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6872</classification-symbol><definition-title>involving mass spectrometry</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with mass spectrometry based sequencing and modifications/improvements thereof.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of&#160;<class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6874</classification-symbol><definition-title>involving nucleic acid arrays, e.g. sequencing by hybridisation</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All applications dealing with nucleic acid array based sequencing and modifications/improvements thereof.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of&#160;<class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6876</classification-symbol><definition-title>Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All nucleic acid products used in the analysis of nucleic acids (e.g. primers, probes, controls) which cannot be classified in any of the subgroups <class-ref scheme="cpc">C12Q1/6879</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q1/6895</class-ref>. If an application relates both to methods and nucleic acid products, than these applications are classified in both the appropriate method and product subgroups.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Differential detection</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6809</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Polymorphism detection by hybridisation</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6827</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Allele specific amplification</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6858</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Probes and primers for the detection of viruses and bacteriophages</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/70</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Virus antigen in a vaccine</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/12</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Modified nucleosides, nucleotides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bacterial and fungal antigens </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/195</class-ref>- <class-ref scheme="cpc">C07K14/40</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Protozoal antigens</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/44</class-ref>- <class-ref scheme="cpc">C07K14/455</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Virus, Bacteriophages</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N7/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bacterial, fungal and protozoan enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">DNA or RNA fragments; Modified forms thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/11</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bacterial vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/70</class-ref>-<class-ref scheme="cpc">C12N15/78</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Vectors for fungal cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/80</class-ref>-<class-ref scheme="cpc">C12N15/815</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Animal vectors and their preparation</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/85</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6883</classification-symbol><definition-title>for diseases caused by alterations of genetic material</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All nucleic acid based diagnostic products. Those include both products for detecting the alterations (polymorphisms including methylation and splice variants) of genetic material and for detecting differential expression of a disease gene. If an application also discloses methods for detecting such polymorphisms or differential expression, the classifier should decide based on the relevance of this method to classify the application also in the appropriate method groups, e.g. <class-ref scheme="cpc">C12Q1/6827</class-ref>, <class-ref scheme="cpc">C12Q1/683</class-ref>, <class-ref scheme="cpc">C12Q1/6858</class-ref>, or <class-ref scheme="cpc">C12Q1/6809</class-ref>.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Primers and probes for cancer assays</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/6886</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Diagnostic immunoassays</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/53</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6886</classification-symbol><definition-title>for cancer  (immunoassay for cancer <class-ref scheme="cpc">G01N33/574</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All nucleic acid based cancer diagnostic products.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Cancer diagnostic immunoassays</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/574</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/6897</classification-symbol><definition-title>involving reporter genes operably linked to promoters</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All methods which use the detection of reporter genes operably linked to promoters for screening and nucleic acid analysis.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Preparation or screening of expression libraries, e.g. reporter assays</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">If the screening or the analysis focuses on protein interaction, expression or activity</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/5008</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/70</classification-symbol><definition-title>involving virus or bacteriophage {(immunoassay for viruses <class-ref scheme="cpc">G01N33/56983</class-ref>)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All methods which are specifically designed for the analysis of viral nucleic acids or for the analysis of nucleic acids of bacteriophages. (NOTE: According to the hierarchy this subgroup should not be limited to analysis involving nucleic acids. In practice, however, as Immunoassays/protein based Biospecific binding assays for viruses are classified in <class-ref scheme="cpc">G01N</class-ref>, this subgroup is effectively limited to analysis of viral/bacteriophagal nucleic acids). Methods which are generally applicable to nucleic acid analysis should also be classified in the relevant <class-ref scheme="cpc">C12Q1/68</class-ref> subgroup.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Immunoassay/protein based Biospecific binding assay for viruses</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/56983</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Virus antigen in a vaccine</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/12</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Virus</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N7/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/701</classification-symbol><definition-title>{Specific hybridization probes}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All probes and primers for the detection and analysis of viruses and bacteriophages not covered by any of the subgroups <class-ref scheme="cpc">C12Q1/703</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q1/708</class-ref>.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/702</classification-symbol><definition-title>{for retroviruses}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Probes and primers for the detection and analysis of retroviruses. Methods specifically designed for retroviruses are covered in <class-ref scheme="cpc">C12Q1/70</class-ref> and <class-ref scheme="cpc">C12Q1/68</class-ref> if necessary.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/703</classification-symbol><definition-title>{Viruses associated with AIDS}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Probes and primers for the detection and analysis of AIDS associated viruses. Methods specifically designed for AIDS associated viruses are covered in <class-ref scheme="cpc">C12Q1/70</class-ref> and <class-ref scheme="cpc">C12Q1/68</class-ref> if necessary.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/705</classification-symbol><definition-title>{for herpetoviridae, e.g. herpes simplex, varicella zoster}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Probes and primers for the detection and analysis of herpetoviridae. Methods specifically designed for herpetoviridae are covered in <class-ref scheme="cpc">C12Q1/70</class-ref> and <class-ref scheme="cpc">C12Q1/68</class-ref> if necessary.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of&#160;<class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/706</classification-symbol><definition-title>{for hepatitis}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Probes and primers for the detection and analysis of hepatitis. Methods specifically designed for hepatitis are covered in <class-ref scheme="cpc">C12Q1/70</class-ref> and <class-ref scheme="cpc">C12Q1/68</class-ref> if necessary.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/707</classification-symbol><definition-title>{non-A, non-B Hepatitis, excluding hepatitis D}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Probes and primers for the detection and analysis of non-A, non-B, and non-D hepatitis. Methods specifically designed for non-A, non-B, and non-D hepatitis are covered in <class-ref scheme="cpc">C12Q1/70</class-ref> and <class-ref scheme="cpc">C12Q1/68</class-ref> if necessary.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q1/708</classification-symbol><definition-title>{for papilloma}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Probes and primers for the detection and analysis of papilloma. Methods specifically designed for papilloma are covered in <class-ref scheme="cpc">C12Q1/70</class-ref> and <class-ref scheme="cpc">C12Q1/68</class-ref> if necessary.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See the &quot;Special rules&quot; section of <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C12Q3/00</classification-symbol><definition-title>Condition responsive control processes  (apparatus therefor <class-ref scheme="cpc">C12M1/36</class-ref>; controlling or regulating in general <class-ref scheme="cpc">G05</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Processes involving enzymes or microorganisms in which a process parameter is measured and that or another process parameter is varied in response to such measurement.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12Q2304/00</classification-symbol><definition-title>Chemical means of detecting microorganisms</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases or esterases</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q2334/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">N-linked chromogens for determinations of peptidases and proteinases</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q2337/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12Q2500/00</classification-symbol><definition-title>Analytical methods involving nucleic acids</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Indexing codes <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref> are only used as subsequent symbols in C-Sets and are not allocated as single symbols.</paragraph-text><paragraph-text type="subheading">C-Sets classification:</paragraph-text><paragraph-text type="body">Indexing codes <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref> are used as subsequent symbols in C-Sets #C12Qa, #C12Na and #C12Nb. The detailed information about the C-Sets construction and the associated syntax rules are found in the &quot;Special rules of classification&quot; in <class-ref scheme="cpc">C12Q1/68</class-ref> for C-Set rule #C12Qa, <class-ref scheme="cpc">C12N15/10</class-ref> for C-Set rule #C12Na, and <class-ref scheme="cpc">C12N15/64</class-ref> for C-Set rule #C12Nb.</paragraph-text><paragraph-text type="subheading">C-Sets searches:</paragraph-text><paragraph-text type="body">C-Sets search queries may be made according to C-Set classification rules #C12Qa, #C12Na or #C12Nb, described in <class-ref scheme="cpc">C12Q1/68</class-ref>, <class-ref scheme="cpc">C12N15/10</class-ref> or <class-ref scheme="cpc">C12N15/64</class-ref>, respectively.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2521/525</classification-symbol><definition-title>Phosphatase</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the detection is based on the release of pyrophosphate, classification is made in group <class-ref scheme="cpc">C12Q2565/301</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2525/143</classification-symbol><definition-title>incorporating a promoter sequence</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the promoter-based amplification (e.g. NASBA, 3SR, TAS) is of relevance, classification is made in group <class-ref scheme="cpc">C12Q2531/143</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2525/185</classification-symbol><definition-title>incorporating bases where the precise position of the bases in the nucleic acid string is important</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Classification in this group is not to be used for 3&apos;-end base.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2525/186</classification-symbol><definition-title>incorporating a non-extendable or blocking moiety</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the incorporation is made in the context of the Sanger sequencing method, i.e. oligonucleotide sequencing using primer elongation and dideoxynucleotides as chain terminators, classification is made in group <class-ref scheme="cpc">C12Q2535/101</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2527/00</classification-symbol><definition-title>Reactions demanding special reaction conditions</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the reaction requires the presence of a metal/ion, classification is made in group <class-ref scheme="cpc">C12Q2563/137</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2533/10</classification-symbol><definition-title>the purpose being to increase the length of an oligonucleotide strand</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the method involves a ligase detection reaction [LDR], classification is made in group <class-ref scheme="cpc">C12Q2561/125</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2533/101</classification-symbol><definition-title>Primer extension</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Allele specific primer extension</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q2535/125</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Characterised by the capture oligonucleotide acting as a primer</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q2565/537</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2533/107</classification-symbol><definition-title>Probe or oligonucleotide ligation</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the ligation is assessed in the context of a ligase chain reaction or of a ligase detection reaction, classification is made in groups <class-ref scheme="cpc">C12Q2531/137</class-ref> or <class-ref scheme="cpc">C12Q2561/125</class-ref>, respectively.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2535/139</classification-symbol><definition-title>Random amplification polymorphism detection [RAPD]</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the reaction is characterized by incorporating arbitrary or random nucleotide sequences, classification is made in group <class-ref scheme="cpc">C12Q2525/179</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2537/137</classification-symbol><definition-title>a displacement step</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the method relates to strand displacement amplification [SDA], classification is made in group <class-ref scheme="cpc">C12Q2531/119</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2537/149</classification-symbol><definition-title>Sequential reactions</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Classification in this group is not to be used for reactions that are implicitly known to be sequential (e.g. amplification reactions).</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2537/155</classification-symbol><definition-title>Cyclic reactions</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the reaction is based on linear amplification, i.e. non exponential, on asymmetric PCR, on PCR, on strand displacement amplification, on rolling circle, on inverse PCR, on ligase chain reaction, on promoter based amplification or on replicase based amplification, classification is made in groups <class-ref scheme="cpc">C12Q2531/101</class-ref> - <class-ref scheme="cpc">C12Q2531/149</class-ref>, respectively. </paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2537/161</classification-symbol><definition-title>A competitive reaction step</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the reaction step is used in the context of a quantitative measurement with a competitive internal standard/control, classification is made in group <class-ref scheme="cpc">C12Q2545/107</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2537/163</classification-symbol><definition-title>blocking probe</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When an enzyme inhibitor or activator is used in the reaction or when a non-extendable or blocking moiety is used in the reaction, classification is made in groups <class-ref scheme="cpc">C12Q2527/127</class-ref>&#160;or <class-ref scheme="cpc">C12Q2525/186</class-ref>, respectively.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2545/114</classification-symbol><definition-title>involving a quantitation step</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the reaction is based on the use of an internal standard/control or on the use of a competitive internal standard/control, or finally on the use of an external standard/control, i.e. control reaction is separated from the test/target reaction, then the classification is made in groups <class-ref scheme="cpc">C12Q2545/101</class-ref>,&#160;<class-ref scheme="cpc">C12Q2545/107</class-ref> or&#160;<class-ref scheme="cpc">C12Q2545/113</class-ref>, respectively.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2549/126</classification-symbol><definition-title>using oligonucleotides as clamps</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When reactions leading to the incorporation of a peptide nucleic acid are involved, classification is made in group <class-ref scheme="cpc">C12Q2525/107</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2563/116</classification-symbol><definition-title>electrical properties of nucleic acids, e.g. impedance, conductivity or resistance</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the label is electroactive, classification is made in group <class-ref scheme="cpc">C12Q2563/113</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2563/119</classification-symbol><definition-title>the label being proteinic</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the capture moiety is a protein for target oligonucleotides, classification is made in group <class-ref scheme="cpc">C12Q2565/531</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2563/125</classification-symbol><definition-title>the label being enzymatic, i.e. proteins, and non proteins, such as nucleic acid with enzymatic activity</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Classification in this group is to be used when enzymes are used as labels.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2565/543</classification-symbol><definition-title>characterised by the use of two or more capture oligonucleotide primers in concert, e.g. bridge amplification</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When the primers are used in sequential reactions, with the exception of uses for reactions implicitly known to be sequential, e.g. amplification reactions, classification is made in group <class-ref scheme="cpc">C12Q2537/149</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-08-01"><classification-symbol scheme="cpc">C12Q2565/627</classification-symbol><definition-title>being a mass spectrometer</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">When a mass label is used in nucleic acid detection, classification is made in group <class-ref scheme="cpc">C12Q2563/167</class-ref>.</paragraph-text></section-body></special-rules></definition-item></definitions>